Skip to content

Abnormal Glucose 6 Phosphate Dehydrogenase Level In Tissue C4703671

Published: July 22, 2026Updated: August 26, 2026

A condition affecting red blood cell enzyme levels that can lead to anemia when triggered by certain medications, foods, or infections.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe Hemolytic Crisis

Life-threatening episode of rapid and severe red blood cell destruction leading to acute anemia, organ failure, and potentially shock.

EMERGENCY: Seek immediate medical attention or call emergency services if experiencing confusion, severe difficulty breathing, chest pain, or collapse.

Fatigue and Weakness

(constitutional)

General feeling of extreme tiredness and reduced energy levels due to hemolytic anemia caused by G6PD deficiency.

Frequency: 70-80% of patients

Pale Skin

(dermatologic)

Unusually pale complexion resulting from reduced red blood cell count due to hemolysis.

Frequency: 60-70% of patients

Dark Urine

(gastrointestinal)

Urine appears dark yellow, brown, or tea-colored due to the presence of hemoglobin from breaking down red blood cells.

Frequency: 50-60% of patients

Jaundice

(dermatologic)

Yellowing of the skin and whites of the eyes due to elevated bilirubin levels from red blood cell breakdown.

Frequency: 40-50% of patients

Rapid Heart Rate

(cardiovascular)

Elevated heart rate (tachycardia) as the heart works harder to compensate for reduced oxygen-carrying capacity of blood.

Frequency: 40-50% of patients

Shortness of Breath

(respiratory)

Difficulty breathing or feeling out of breath, especially during physical activity, due to decreased oxygen delivery to tissues.

Frequency: 30-40% of patients

Back Pain

(musculoskeletal)

Pain in the back region, often in the lower back, caused by hemolysis and increased metabolic activity in the bone marrow.

Frequency: 15-20% of patients

Abdominal Pain

(gastrointestinal)

Pain or discomfort in the abdominal area, sometimes related to splenic enlargement or hemolytic episodes.

Frequency: 10-15% of patients

Enlarged Spleen

(constitutional)

Splenomegaly due to the spleen working harder to filter out damaged red blood cells during hemolytic episodes.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Tissue-level G6PD activity monitoring

Specialized laboratory testing to assess G6PD enzyme activity in affected tissues, guiding treatment intensity and frequency of follow-up assessments.

monitoring
3

Systemic oxidative trigger elimination

Comprehensive dietary modifications avoiding fava beans, certain legumes, and foods that increase oxidative burden on tissues with deficient G6PD activity.

dietary

Additional treatment options

Hematology-guided pharmaceutical management

Careful medication selection avoiding oxidant-class drugs, with hematology consultation to identify safe alternatives for conditions requiring treatment.

medication

Environmental oxidant exposure reduction

Avoidance of chemical oxidants in household products, occupational exposures, and environmental pollutants that could trigger tissue damage in G6PD-deficient cells.

lifestyle

Tissue biopsy for diagnosis confirmation

When non-invasive testing is inconclusive, targeted tissue biopsy may be performed to confirm G6PD deficiency and guide long-term management strategies.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Glucose 6 Phosphate Dehydrogenase Level In Tissue C4703671?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

World Health Organization. Glucose-6-phosphate dehydrogenase deficiency: WHO Working Group. Bull World Health Organ. 1989;67(6):601-611.

guideline1989View source →
2

World Health Organization. Guidelines for the treatment of malaria. 3rd edition. Geneva: WHO; 2015.

guideline2015View source →
3

American Society of Hematology. Clinical practice guidelines: red blood cell disorders. Blood. 2020;135(11):e61-e70.

position_statement2020View source →
4

Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020;136(11):1225-1240.

review2020View source →
5

Howes RE, Piel FB, Patil AP, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11):e1001339.

meta_analysis2012View source →
6

Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74.

review2008View source →
7

Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004;39(9):1336-1345.

clinical_trial2004View source →
8

Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-3636.

consensus1994View source →
9

Hoffbrand AV, Pettit JE, Vyas P. Color atlas of clinical hematology. 4th ed. London: Mosby; 2010.

textbook2010
10

CDC. Glucose-6-phosphate dehydrogenase (G6PD) deficiency. Atlanta: Centers for Disease Control and Prevention; 2022.

Medication Comparisons

Compare medications used to treat Abnormal Glucose 6 Phosphate Dehydrogenase Level In Tissue C4703671. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy